Bridgewater Associates, LP sold ALAB · INSIDER
Data sources SEC Form 4 1h ago
House PTR 1h ago
SEC 13F 1h ago
Robinhood Chain 1h ago
SEC 13F / TRIM Verified data
BA 13F filer · Astera Labs, Inc. · ASTERA LABS INC
○ Watch ALAB○ Watch filer
Side SELL
Δ value $362.24M
Shares 749.9K
Price $483.02
Executed Not disclosed
Disclosed Aug 14, 2026 Customize layout
ALAB · daily Yahoo Finance chart API
◉ This trade, on the day it was made▼ Disclosure● Material company filing◯ Other disclosed buy◯ Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Insider Score Experimental signal Transaction type +6 / 20
TRIM
Relative size +18 / 25
$362.2M quarter-over-quarter change
Filing timing 0 / 15
Not applicable — 13F reports quarter-end holdings, execution dates are not disclosed
Historical behavior +8 / 15
First recorded trade by this actor in this security
Frequency & clustering +15 / 15
3 other actors traded the same direction within 14 days
Market events 0 / 10
No material company filing within 60 days after the trade
Other disclosed activity · ALAB Score Actor Security Side Value Executed Disclosed Lag Source Evidence 15 DA Dyckerhoff Stefan A Director
ALAB Astera Labs, Inc. Open-market sale · 10b5-1 plan
SELL $741K 3,505 sh
Nov 5, 2026 Nov 9, 2026
Verified data Read directly from the primary public document; every field below is as reported by the filer.
Source
Publisher U.S. Securities and Exchange Commission (EDGAR)
Document ID 0001350694-26-000003 Timestamps
Event (reported) Not reported
Published Aug 14, 2026
Ingested by INSIDER Nov 4, 22:39 UTC
Last re-read Nov 10, 08:27 UTC Extracted facts
Filer Bridgewater Associates, LP
Role 13F filer
Transaction TRIM
Asset ASTERA LABS INC
Ticker ALAB
Shares 749.9K
Price per share $483.02
Value $362,240,004
Owned after transaction 992 shares What this establishes Bridgewater Associates, LP reported this position change in a quarterly 13F holdings report. 13F shows quarter-end positions only — it does not say when during the quarter shares were bought or sold.
Extraction
Method 13F information table XML
Confidence 1.00
13F filer Bridgewater Associates, LPcik:0001350694
Issuer Astera Labs, Inc.cik:0001736297 Revision history · 0 No field has changed since this record was first ingested.
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
16 DA Dyckerhoff Stefan A Director
ALAB Astera Labs, Inc. Open-market sale · 10b5-1 plan
SELL $140K 661 sh
Nov 5, 2026 Nov 9, 2026traded Nov 5, 2026
+4d SEC Form 4 Evidence
Evidence Close
14 DA Dyckerhoff Stefan A Director
ALAB Astera Labs, Inc. Open-market sale · 10b5-1 plan
SELL $1.76M 8,333 sh
Nov 5, 2026 Nov 9, 2026traded Nov 5, 2026
+4d SEC Form 4 Evidence
Evidence Close
19 HE Hurlston Michael E. Director
ALAB Astera Labs, Inc. Grant or award
A $22K 72 sh
Oct 1, 2026 Oct 9, 2026traded Oct 1, 2026
+8d SEC Form 4 Evidence
Evidence Close
38 MJ Mohan Jitendra Director, Chief Executive Officer
ALAB Astera Labs, Inc. Open-market sale
SELL $5.99M 17.4K sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
32 MP Mazzara Philip General Counsel and Secretary
ALAB Astera Labs, Inc. Open-market sale
SELL $93K 269 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
38 MJ Mohan Jitendra Director, Chief Executive Officer
ALAB Astera Labs, Inc. Open-market sale
SELL $2.31M 6,926 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 MP Mazzara Philip General Counsel and Secretary
ALAB Astera Labs, Inc. Open-market sale
SELL $269K 797 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 MJ Mohan Jitendra Director, Chief Executive Officer
ALAB Astera Labs, Inc. Open-market sale
SELL $693K 1,984 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 MJ Mohan Jitendra Director, Chief Executive Officer
ALAB Astera Labs, Inc. Open-market sale
SELL $368K 1,049 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 GS Gajendra Sanjay Director, President and COO
ALAB Astera Labs, Inc. Open-market sale
SELL $693K 1,984 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 MJ Mohan Jitendra Director, Chief Executive Officer
ALAB Astera Labs, Inc. Open-market sale
SELL $368K 1,057 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 GS Gajendra Sanjay Director, President and COO
ALAB Astera Labs, Inc. Open-market sale
SELL $891K 2,616 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
29 MP Mazzara Philip General Counsel and Secretary
ALAB Astera Labs, Inc. Open-market sale
SELL $28K 81 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
38 GS Gajendra Sanjay Director, President and COO
ALAB Astera Labs, Inc. Open-market sale
SELL $1.21M 3,500 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
38 GS Gajendra Sanjay Director, President and COO
ALAB Astera Labs, Inc. Open-market sale
SELL $4.21M 12.6K sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 MJ Mohan Jitendra Director, Chief Executive Officer
ALAB Astera Labs, Inc. Open-market sale
SELL $550K 1,610 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 MP Mazzara Philip General Counsel and Secretary
ALAB Astera Labs, Inc. Open-market sale
SELL $452K 1,310 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
32 MP Mazzara Philip General Counsel and Secretary
ALAB Astera Labs, Inc. Open-market sale
SELL $180K 540 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
35 GS Gajendra Sanjay Director, President and COO
ALAB Astera Labs, Inc. Open-market sale
SELL $598K 1,782 sh
Aug 17, 2026 Aug 19, 2026traded Aug 17, 2026
+2d SEC Form 4 Evidence
Evidence Close
May 5, 2026
